Skip to main content
NIH funding notice RFA-DK-14-014

Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)

Closed on November 24, 2014.

Posted
May 14, 2014
Close date
November 24, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,537,146 in first-year total cost, median $1,768,573.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-9 (M1)]2

Most frequent institutions

  1. CLINICAL RESEARCH INSTITUTE OF MONTREAL1
  2. MAYO CLINIC ROCHESTER1
Competing awards under RFA-DK-14-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and sensor-augmented pump therapy in outpatient settings1DP3DK106930-01RABASA-LHORET, REMICLINICAL RESEARCH INSTITUTE OF MONTREAL, QC$2,509,367ZDK1
2015Relative Efficacy of Single-, Bi-, and Tri-Hormonal Closed-Loop Control Systems1DP3DK106785-01BASU, ANANDAMAYO CLINIC ROCHESTER, MN$1,027,779ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.